Your browser doesn't support javascript.
loading
Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy.
Kim, Gloria B; Fritsche, Jens; Bunk, Sebastian; Mahr, Andrea; Unverdorben, Felix; Tosh, Kevin; Kong, Hong; Maldini, Colby R; Lau, Chui; Srivatsa, Sriram; Jiang, Shuguang; Glover, Joshua; Dopkin, Derek; Zhang, Carolyn X; Schuster, Heiko; Kowalewski, Daniel J; Goldfinger, Valentina; Ott, Martina; Fuhrmann, David; Baues, Maike; Boesmueller, Hans; Schraeder, Christoph; Schimmack, Gisela; Song, Colette; Hoffgaard, Franziska; Roemer, Michael; Tsou, Chih-Chiang; Hofmann, Martin; Treiber, Thomas; Hutt, Meike; Alten, Leonie; Jaworski, Maike; Alpert, Amir; Missel, Sarah; Reinhardt, Carsten; Singh, Harpreet; Schoor, Oliver; Walter, Steffen; Wagner, Claudia; Maurer, Dominik; Weinschenk, Toni; Riley, James L.
Afiliação
  • Kim GB; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Fritsche J; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Bunk S; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Mahr A; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Unverdorben F; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Tosh K; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Kong H; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Maldini CR; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Lau C; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Srivatsa S; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Jiang S; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Glover J; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Dopkin D; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Zhang CX; Department of Microbiology, Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Schuster H; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Kowalewski DJ; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Goldfinger V; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Ott M; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Fuhrmann D; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Baues M; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Boesmueller H; Institute of Pathology and Neuropathology, Eberhard Karls University, 72076 Tuebingen, Germany.
  • Schraeder C; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Schimmack G; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Song C; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Hoffgaard F; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Roemer M; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Tsou CC; Immatics US, 2201 W. Holcombe Blvd., Suite 205, Houston, TX 77030, USA.
  • Hofmann M; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Treiber T; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Hutt M; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Alten L; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Jaworski M; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Alpert A; Immatics US, 2201 W. Holcombe Blvd., Suite 205, Houston, TX 77030, USA.
  • Missel S; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Reinhardt C; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Singh H; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Schoor O; Immatics US, 2201 W. Holcombe Blvd., Suite 205, Houston, TX 77030, USA.
  • Walter S; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Wagner C; Immatics US, 2201 W. Holcombe Blvd., Suite 205, Houston, TX 77030, USA.
  • Maurer D; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Weinschenk T; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
  • Riley JL; Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany.
Sci Transl Med ; 14(660): eabo6135, 2022 08 31.
Article em En | MEDLINE | ID: mdl-36044599
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T / Imunoterapia Adotiva Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T / Imunoterapia Adotiva Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article